Quotes 5-day view Delayed Xetra
02/01/2023
02/02/2023
02/03/2023
02/06/2023
02/07/2023
Date
182.5(c)
184.05(c)
185.9(c)
184.3(c)
182.65(c)
Last
644 977
471 010
350 838
208 592
273 960
Volume
-4.48%
+0.85%
+1.01%
-0.86%
-0.90%
Change
Estimated financial data (e) EUR USD
Sales 2022
22 263 M
23 811 M
23 811 M
Net income 2022
3 681 M
3 937 M
3 937 M
Net Debt 2022
7 082 M
7 574 M
7 574 M
P/E ratio 2022
21,6x
Yield 2022
1,11%
Sales 2023
22 927 M
24 521 M
24 521 M
Net income 2023
3 746 M
4 007 M
4 007 M
Net Debt 2023
5 055 M
5 407 M
5 407 M
P/E ratio 2023
21,2x
Yield 2023
1,15%
Capitalization
79 412 M
84 933 M
84 933 M
EV / Sales 2022
3,89x
EV / Sales 2023
3,68x
Nbr of Employees
63 723
Free-Float
29,7%
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- solutions and products for scientific and biotechnological research (45.7%);
- pharmaceutical products (36%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders,...
All news about MERCK KGAA
News in other languages on MERCK KGAA
Analyst Recommendations on MERCK KGAA
MERCK KGAA - 01/13
Technically solid
BUY
ETFs positioned on MERCK KGAA ETFs and Trackers with Trackinsight
Merck picks Goldman Sachs to launch pigments sale in 2023 - sources
MERCK KGAA A European big pharma with positive momentum
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends MERCK KGAA
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
182,65 €
Average target price
207,85 €
Spread / Average Target
13,8%
Please enable JavaScript in your browser's settings to use dynamic charts.